EMIG - Changes to the EU pharmaceutical legislation and its impact on the UK
Please join us for a practical, interactive webinar on EU pharmaceutical legislation and its impact on the UK.
The speakers will be Wendy Dodd, Associate Director of Regulatory, and Neil Prideaux, Regulatory Manager, at the regulatory, PV and Quality consultancy group, regenold. They will walk you through the key changes arising from the new EU pharmaceutical legislation and what they mean for those operating in the UK market.
Key topics include:
Key changes in the EU: An overview of the most significant updates to the EU regulatory framework and their implications for the UK.
Fostering innovation: How the revised framework is designed to support and encourage innovation across the pharmaceutical sector.
Patient access to medicines: Exploring the measures being introduced to improve patient access and what this means in practice.
Medicine shortages: The new safeguards being put in place to strengthen resilience against medicine shortages.
Environmental protection and antimicrobial resistance: A look at the enhanced environmental protections and the growing focus on tackling antimicrobial resistance.
The webinar will also provide an opportunity for attendees to ask questions.
The session will be chaired by: Paul Gershlick, Co-Chair of the EMIG Compliance Special Interest Group, and Partner and Head of Pharma and Life Sciences at the law firm, VWV; and Paul Ranson, EMIG Legal Advisor and VWV.
